Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Antimicrob Chemother ; 66(2): 283-6, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21147826

RESUMO

OBJECTIVES: To investigate the role of a putative small multidrug resistance transporter, annotated in Enterococcus faecalis V583 genome as EFA0010 (we will refer to this gene as qacZ), in decreased susceptibility to biocides. METHODS: A derivative strain of V583, susceptible to erythromycin (V583ErmS), was complemented with pORI23 carrying the qacZ gene (strain EF-SAVE1). MICs of benzalkonium chloride, chlorhexidine and ethidium bromide were determined for the complemented strain and wild-type. RT-PCR and ethidium bromide efflux assays were performed in order to fully understand the role and specificity of the qacZ gene. The presence of qacZ in 73 enterococcal strains from different origins was investigated by PCR, and MICs of benzalkonium chloride and chlorhexidine were determined for the same strains. RESULTS: The complemented strain, EF-SAVE1, presented a higher MIC of benzalkonium chloride (8 mg/L) than V583ErmS (4 mg/L); the MICs of chlorhexidine and ethidium bromide were the same for both strains, 4 mg/L and 16 mg/L, respectively. Expression of qacZ was found to be higher in EF-SAVE1 and constitutive, i.e. not inducible by any of the three tested biocides. Overexpression of qacZ was not responsible for changes in ethidium bromide efflux. This gene was present in 52% of the enterococcal isolates studied and the MICs of benzalkonium chloride and chlorhexidine ranged between 2 and 8 mg/L. CONCLUSIONS: We demonstrate the involvement of the qacZ gene in tolerance to the quaternary ammonium compound benzalkonium chloride, but not ethidium bromide. This work constitutes the first report of a biocide resistance mechanism in E. faecalis, and reveals its dissemination amongst the genus Enterococcus.


Assuntos
Proteínas de Bactérias/metabolismo , Compostos de Benzalcônio/farmacologia , Clorexidina/farmacologia , Farmacorresistência Bacteriana Múltipla/efeitos dos fármacos , Enterococcus/efeitos dos fármacos , Enterococcus/metabolismo , Proteínas de Membrana Transportadoras/metabolismo , Proteínas de Bactérias/genética , Eritromicina/farmacologia , Etídio/farmacologia , Proteínas de Membrana Transportadoras/genética , Testes de Sensibilidade Microbiana , Reação em Cadeia da Polimerase , Alinhamento de Sequência , Análise de Sequência de Proteína
2.
Biochimie ; 87(9-10): 819-26, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15885870

RESUMO

In all living cells 3' ends of RNA are posttranscriptionally elongated or shortened by nucleotidyl transferases and ribonucleases. The detailed analysis of the rpsO mRNA of Escherichia coli presented here demonstrates that transcription terminates in vivo at two sites located seven and eight nucleotides downstream from the GC-rich hairpin of the intrinsic terminator and that primary transcripts can be shortened by RNase II. The shortest RNA identified in the cell result from nibbling of primary transcripts. Primary transcripts and nibbled molecules can also be adenylated by poly(A) polymerase I (PAP I). In addition, kinetics of decay performed in vitro demonstrate that RNase II rapidly degrades poly(A) tails longer than 7-8 As processively while it slowly nibbles shorter tails and non adenylated RNAs distributively. Comparison of the kinetics of nibbling of oligoadenylated rpsO mRNA in vivo and in vitro lead us to conclude that the rates of shortening and elongation of the oligo(A) tails detected in vivo are very slow: about 0.5-7 nucleotides per min. We finally speculate that the slowness of oligo(A) synthesis may explain why polyadenylation does not affect the stability of mRNAs whose degradation is controlled by RNase E.


Assuntos
Proteínas de Escherichia coli/biossíntese , Escherichia coli/genética , Exorribonucleases/metabolismo , Poli A/metabolismo , Polinucleotídeo Adenililtransferase/metabolismo , RNA Mensageiro/biossíntese , Transcrição Gênica , Animais , Sequência de Bases , Catálise , Escherichia coli/metabolismo , Conformação de Ácido Nucleico , Estabilidade de RNA , Regiões Terminadoras Genéticas
3.
Mol Microbiol ; 50(4): 1283-94, 2003 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-14622415

RESUMO

In Escherichia coli, RNA degradation is mediated by endonucleolytic processes, frequently mediated by RNase E, and also by a poly(A)-dependent mechanism. The dominant pathway of decay of the rpsO transcripts is initiated by an RNase E cleavage occurring at a preferential site named M2. We demonstrate that mutations which prevent this cleavage slow down degradation by RNase E. All these mutations reduce the single-stranded character of nucleotides surrounding the cleavage site. Moreover, we identify two other cleavage sites which probably account for the slow RNase E-mediated degradation of the mutated mRNAs. Failure to stabilize the rpsO transcript by appending a 5' hairpin indicates that RNase E is not recruited by the 5' end of mRNA. The fact that nucleotide substitutions which prevent cleavage at M2 facilitate the poly(A)-dependent degradation of the rpsO transcripts suggest an interplay between the two mechanisms of decay. In the discussion, we speculate that a structural feature located in the vicinity of M2 could be an internal degradosome entry site promoting both RNase E cleavages and poly(A)-dependent degradation of the rpsO mRNA. We also discuss the role of poly(A)-dependent decay in mRNA metabolism.


Assuntos
Endorribonucleases/metabolismo , Escherichia coli/genética , RNA Bacteriano/metabolismo , RNA Mensageiro/metabolismo , Proteínas Ribossômicas/genética , Escherichia coli/metabolismo , Conformação de Ácido Nucleico , Estabilidade de RNA , RNA Bacteriano/genética , Proteínas Ribossômicas/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...